Setting the standard in Medicaid access consulting – from drug launch strategy to supplemental rebate bid analysis to product monitoring.
Artia Solutions – Powered by Petauri partners with drug manufacturers to develop launch strategies, forecast and improve Medicaid access, design financial rebate models, resolve clinical and reimbursement challenges, and navigate complex government regulations and policies.
No matter where a product falls in the pre- or post-launch pipeline, we deliver the strategy that secures favorable Medicaid access while protecting profitability.
We streamline Medicaid drug launch strategy for both pharmacy and medical benefit products, as well as non-drug categories such as medical and diabetic supplies.
We accurately predict pre-launch access levels, define coverage requirements within a therapeutic class, identify barriers, calculate supplemental rebate needs, and develop clinical messaging through engagement with key state decision-makers.
Our custom-built tools provide clients with an in-depth analytical view of their PDL category, informing whether to participate in a supplemental rebate bid and what level of rebate is needed to remain competitive.
We also support bid submission, competitor net cost forecasting, federal unit rebate impact modeling, gross-to-net ROI revenue analysis, and Medicaid utilization and cost data reporting.
We track the status of our clients’ and their competitor’s products through Capsule, a proprietary, custom-built platform that surfaces updates on product and class status, new PDLs, P&T and DUR meeting information, market share data, and clinical and bid vendor activity.
We tailor the level of support to each client’s needs, working as an extension of their team or leading their Medicaid account management function. Our experienced market access team works alongside clients on Medicaid strategy development, engagement, and pull-through.
We study the latest federal and state policies to provide clients with timely, relevant information about how legislative and regulatory changes impact their drugs on Medicaid and the pharmaceutical industry.
Through our Advantage+ offering, including exclusive webinars, newsletters, and one-on-one strategic calls, we help teams stay one step ahead of evolving legislation and policy.
We support the biannual Crossroads: An Artia Solutions Conference, convening Medicaid pharmacy administrators, Managed Care representatives, drug manufacturers, healthcare providers, pharmacists, advocacy groups, patients, and public officials for impactful dialogue. Our goal is to ignite bold conversations about pharmaceutical trends, healthcare reform, new regulations, and state-level priorities shaping the future of Medicaid.
Save the Date: We hope you will join us for the next Crossroads conference on June 14-16, 2027.
Expert Insights, Industry News, and Upcoming Events